Suchergebnisse - "Lu, Zhongzheng"

PubPharm (6)

1

Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl

enthalten in: Molecular cancer | 2010

von Lu, Z. | Jin, Y. | Chen, C. | +3

ErratumIn: Mol Cancer. 2021 Dec 31;20(1):172. - PMID 34969396

2

Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation

enthalten in: Cancer letters | 2010

von Lu, Z. | Jin, Y. | Qiu, L. | +2

3

GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells

enthalten in: Cancer biology & therapy | 2010

von Shi, X. | Wang, D. | Ding, K. | +4

4

Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells : inactivation of the NF-kappaB pathway and generation of reactive oxygen species

enthalten in: Cancer research | 2010

von Jin, Y. | Lu, Z. | Ding, K. | +7

5

Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives : Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl

enthalten in: Bioorganic & medicinal chemistry | 2010

von Xu, F. | Shi, X. | Li, S. | +6

6

The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation

enthalten in: Molecular cancer therapeutics | 2010

von Jin, Y. | Lu, Z. | Cao, K. | +5

1
[1]